As CRISPR emerges, researchers spotlight positive effects in prenatal gene editing treatment for mice
In a breakthrough for the buzzing world of CRISPR research, a team of scientists has demonstrated a use of the gene editing tool to treat a genetic disease in mice before they are born.
The proof-of-concept study brings them one step closer — though still miles away — to the ultimate goal of treating severe human diseases diagnosed early in pregnancy, according to the researchers from Children’s Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
